GSK-J4
| CAS No. | 1373423-53-0 | Cat. No. | BCP08261 |
| Name | GSK-J4 | ||
| Synonyms | GSKJ4;GSK J4; GSK-J-4; GSK-J 4; | ||
| Formula | C24H27N5O2 | M. Wt | 417.5 |
| Description | GSK-J4 is a cell permeable, potent and selective histone demethylase. GSK-J4 is a prodrug of GSK J1, which is the first selective inhibitor of the H3K27 histone demethylase JMJD3 and UTX with IC50 of 60 nM in a cell-free assay and inactive against a panel of demethylases of the JMJ family. GSK-J4 is used to probe the consequences of demethylation of H3K27me3. GSK-J4 inhibits the lipopolysaccharide-induced production of cytokines, including pro-inflammatory tumour necrosis factor (TNF). | ||
| Pathways | Epigenetics | ||
| Targets | Histone Demethylase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.